Medication Treatment for Dermatillomania (Skin Picking Disorder)
N-acetylcysteine should be initiated as the first-line pharmacological treatment for this patient with dermatillomania, starting at 1200-2400 mg daily, as it has demonstrated superiority over placebo in three out of five randomized controlled trials and carries minimal side effects. 1
Treatment Algorithm
Step 1: First-Line Behavioral Therapy (Always Initiate)
- Habit reversal training is the primary treatment modality and should be started immediately for all patients with dermatillomania 1
- Deliver 10-20 sessions of cognitive-behavioral therapy, either in-person or internet-based 1
- Awareness training helps identify triggers, situations, and early warning signs preceding picking episodes 1
- Competing response training teaches alternative behaviors when urges emerge 1
- Patient adherence to between-session homework is the strongest predictor of treatment success, so emphasize this heavily 1
Step 2: Add Pharmacotherapy (When Behavioral Therapy Alone Is Insufficient)
First-Line Medication: N-Acetylcysteine
- Start N-acetylcysteine at 1200 mg daily, titrating up to 2400 mg daily as tolerated 1
- This is preferred over other medications due to significant benefits with low side effect risk 1
- Monitor response over 8-12 weeks before declaring treatment failure
Second-Line Medication: Clomipramine (If N-Acetylcysteine Fails)
- Initiate clomipramine only after N-acetylcysteine trial 1
- Requires 8-12 weeks at maximum tolerated dose before declaring treatment failure - do not discontinue prematurely 1
- Monitor for serious adverse effects including seizures, cardiac arrhythmias, and serotonergic syndrome, especially when combined with other serotonergic agents 1
Alternative Options: SSRIs
- Selective serotonin reuptake inhibitors (fluoxetine, sertraline, others) have shown effectiveness in treating the psychiatric component of dermatillomania 2, 3
- Consider when comorbid depression, anxiety, or OCD is present 2
- Fluoxetine inhibits CYP2D6 and may interact with other medications; initiate at low doses if combining with drugs metabolized by this pathway 4
Special Consideration: Atomoxetine
- If comorbid ADHD is present, atomoxetine (selective noradrenaline reuptake inhibitor) may address both conditions simultaneously 5
- This represents a targeted approach when ADHD symptoms coexist with skin picking
Treatment Duration and Maintenance
- Continue successful interventions for at least 12-24 months after achieving remission, given the chronic nature of dermatillomania 1
- Develop a relapse prevention plan identifying triggers, warning signs, and action steps 1
- Some patients may require longer-term or indefinite treatment depending on severity and response
Concurrent Management of Skin Lesions
- Treat active wounds with topical wound care and antibiotics if infected 2, 6
- Address pruritus if present with topical antipruritics containing menthol 0.5% or topical corticosteroids (mometasone furoate 0.1% or betamethasone valerate 0.1%) 7
- Apply moisturizers to prevent dry skin, which can trigger picking behavior 7
Critical Pitfalls to Avoid
- Do not discontinue clomipramine before completing 8-12 weeks at maximum tolerated dose - premature discontinuation is a common error 1
- Do not overlook comorbid psychiatric conditions (OCD, anxiety, depression, ADHD, borderline personality disorder) that require concurrent treatment 2
- Do not rely solely on medication without behavioral therapy - the combination is superior to either alone 1, 2
- Monitor for serious complications including deep tissue infections, osteomyelitis, or epidural abscess in severe cases with chronic wounds 6